Correction to: Nature Communications https://doi.org/10.1038/s41467-019-11454-9, online 7 August 2019.
The original version of this articles omitted a reference to previous work on the early use of lentiviral vectors in the clinic, reported in Biffi et al. Science 341, https://doi.org/10.1126/science.1233158 (2013); Epub 11 Jul 2013) . This has now been added as reference number 57. In the previous version of the article, the article text stated: ‘Lentiviral vectors recently reached the clinic for the treatment of a severe combined immunodeficiency56’. This text has been corrected to state: ‘Lentiviral vectors recently reached the clinic for the treatment of different types of genetic diseases56,57’.
This has been corrected in both the PDF and HTML versions of the Article.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Maule, G., Casini, A., Montagna, C. et al. Author Correction: Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing. Nat Commun 11, 5457 (2020). https://doi.org/10.1038/s41467-020-19351-2
Published:
DOI: https://doi.org/10.1038/s41467-020-19351-2
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
